Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. uri icon

Overview

publication date

  • August 23, 2013

Research

keywords

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Pyrimidines
  • Sulfonamides

Identity

Scopus Document Identifier

  • 84888624978

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2013.08.043

PubMed ID

  • 24209513

Additional Document Info

volume

  • 190

issue

  • 6